亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

干酪素鈉

 
 
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 上海付款后3天內(nèi)
品牌 上海一研
≥99.0% 10CM*20CM
過期 長期有效
更新 2020-09-27 18:29
 

上海一研生物科技有限公司

企業(yè)會員第6年
資料未認(rèn)證
保證金未繳納
  • 上海
  • 上次登錄 2023-10-10
  • 吳小姐 (先生)  
詳細(xì)說明
中文名稱: 干酪素鈉
其他中文名稱: 酪蛋白鈉;酪朊酸鈉
英文名稱: Casein Na salt
其他英文名稱: Casein sodium salt from bovine milk
產(chǎn)品規(guī)格: BR,90%
包裝: 25克/100克/500克
CAS號:9005-46-3
級別:BR
蛋白質(zhì):≥90%
PH:6.0~7.5
溶解度(60-70):≥99%
脂肪:≤2.0%
乳糖:≤1.0%
灰份:≤6.0%
粘度(15%20℃):500-2000
大腸桿菌:≤40/100g
霉菌:≤50/100g
性狀:乳白色。無臭、無味或稍有特異香氣和味道。易溶于或分散在水中,水溶液pH值6.0~7.5。其水溶液遇酸會產(chǎn)生酪蛋白沉淀。在94℃下加熱10s或121℃下加熱5s均不結(jié)塊。是高質(zhì)量牛奶蛋白產(chǎn)品
用途:生化研究。乳化、穩(wěn)定和蛋白質(zhì)強(qiáng)化劑作用
保存:RT



舉報(bào)收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
曲拉通x-405 潤濕劑P-40 曲拉通x-100 曲拉通x-114 曲拉通x-200 曲拉通x-405 潤濕劑P-40 OED60K型發(fā)酵工業(yè)通用消泡劑
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |